Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Freeze-dried trivalent antivenom for snakebites in the Brazilian Amazon
ISRCTN12845255Phase 2Completed
- Sponsor
- Instituto de Biologia do Exército
- Start
- Jun 2005
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of trivalent antivenom, bothrops antivenom, Bothrops-Lachesis antivenom and bothrops-crotalus antivenom in snakebite envenomation (2 arms), sponsored by Instituto de Biologia do Exército. Primary endpoint: Early adverse reactions of antivenom therapy. Started Jun 2005; status: completed.
02
Drugs
trivalent antivenombothrops antivenomBothrops-Lachesis antivenombothrops-crotalus antivenom
03
Conditions
snakebite envenomation
Beyond the preview
Go deeper on ISRCTN12845255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12845255.